Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001001277-02-000169
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR 12/31/01 form10k.txt 10-K 179169
3 EXHIBIT 10.12 - JOINT RESERACH PROJECT AGREEMENT ex10-12.txt EX-10 3045
4 EXHIBIT 10.13 - PATENT DEVELOPMENT AGREEMENT ex10-13.txt EX-10 47710
5 EXHIBIT 10.14 PROJECT DEVELOPMENT AGREEMENT ex10-14.txt EX-10 47104
6 EXHIBIT 23.1 - CONSENT OF INDEPENDENT ACCOUNTANTS ex23-1.txt EX-23 1010
  Complete submission text file 0001001277-02-000169.txt   280021
Mailing Address 543 GRANVILLE STREET SUITE 1200 VANCOUVER BRITISH COLUMBIA CANADA V6C1X VANCOUVER BRITISH CO
Business Address 543 GRANVILLE STREET SUITE 1200 VANCOUVER BC V6C 1X8 A1
DRAGON PHARMACEUTICALS INC (Filer) CIK: 0001075206 (see all company filings)

Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27937 | Film No.: 02597256
SIC: 2834 Pharmaceutical Preparations